CMP-001 in Combination With Nivolumab in Subjects With Advanced Melanoma

Name: CMP-001 in Combination With Nivolumab in Subjects With Advanced Melanoma
License: Public Domain

Regeneron Pharmaceuticals

ClinicalTrials.gov · Datasets · License: Public Domain

melanoma, advanced melanoma, metastatic melanoma, unresectable melanoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 252993
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.